Pages that link to "Q36407176"
Jump to navigation
Jump to search
The following pages link to Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. (Q36407176):
Displaying 50 items.
- Physical function and quality of life in patients with chronic GvHD: a summary of preclinical and clinical studies and a call for exercise intervention trials in patients (Q26787230) (← links)
- Secondary treatment of acute graft-versus-host disease: a critical review (Q26823275) (← links)
- National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report (Q26827651) (← links)
- Treatment of chronic graft-versus-host disease in 2011 (Q26851433) (← links)
- Graft-versus-host disease affecting oral cavity. A review (Q27004303) (← links)
- Wharton's Jelly-Derived Mesenchymal Stromal Cells as a Promising Cellular Therapeutic Strategy for the Management of Graft-versus-Host Disease (Q28083027) (← links)
- The role of photopheresis in the treatment of graft-versus-host disease (Q28280153) (← links)
- A systematic review of studies that aim to determine which outcomes to measure in clinical trials in children (Q28472665) (← links)
- Content Validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as Assessed by Cognitive Interviews (Q30749782) (← links)
- Guideline on the clinical use of apheresis procedures for the treatment of patients and collection of cellular therapy products. British Committee for Standards in Haematology (Q33165774) (← links)
- Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease (Q33385079) (← links)
- Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study (Q33397272) (← links)
- Assessment of joint and fascia manifestations in chronic graft-versus-host disease (Q33583436) (← links)
- Rationale and Design of the Chronic GVHD Cohort Study: Improving Outcomes Assessment in Chronic GVHD (Q33591662) (← links)
- Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease. (Q33608255) (← links)
- Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement (Q33622648) (← links)
- Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease (Q33725411) (← links)
- Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns (Q33754654) (← links)
- Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD). (Q33774650) (← links)
- Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium (Q33830644) (← links)
- Chronic graft-versus-host disease (GVHD) in children. (Q33857680) (← links)
- Current issues in chronic graft-versus-host disease (Q33917187) (← links)
- Favorable outcomes in patients surviving 5 or more years after allogeneic hematopoietic stem cell transplantation for hematologic malignancies (Q33965200) (← links)
- Graft-versus-host disease: state of the science (Q33977923) (← links)
- Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation (Q34020720) (← links)
- FFS: an end(point) to our problems in chronic GVHD trials? (Q34077766) (← links)
- Failure-free survival after initial systemic treatment of chronic graft-versus-host disease (Q34077787) (← links)
- Assessment of health-related quality of life in pediatric hematopoietic stem cell transplant recipients: progress, challenges and future directions (Q34160274) (← links)
- Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study (Q34255166) (← links)
- Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host disease (Q34279929) (← links)
- Muscle cramps and neuropathies in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host disease (Q34427665) (← links)
- Mesenchymal stem cell as salvage treatment for refractory chronic GVHD (Q34562177) (← links)
- Have we made progress in the management of chronic graft-vs-host disease? (Q34644980) (← links)
- Extracorporeal Photochemotherapy as a Challenging Treatment for Cutaneous T-Cell Lymphoma, Acute and Chronic Graft-versus-Host Disease, Organ Rejection and T-Lymphocyte-Mediated Autoimmune Diseases (Q34870346) (← links)
- Guidelines on the use of extracorporeal photopheresis (Q34918643) (← links)
- How we treat chronic graft-versus-host disease (Q35004923) (← links)
- Evolution of the donor T-cell repertoire in recipients in the second decade after allogeneic stem cell transplantation. (Q35029449) (← links)
- A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change. (Q35172772) (← links)
- Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP) (Q35174524) (← links)
- The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II study (Q35193763) (← links)
- Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria (Q35483810) (← links)
- Treatment of chronic graft-versus-host disease: Past, present and future (Q35524687) (← links)
- Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease (Q35588726) (← links)
- Humanized anti-CD25 monoclonal antibody treatment of steroid-refractory acute graft-versus-host disease: a Chinese single-center experience in a group of 64 patients (Q35669073) (← links)
- NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: health-related quality of life, functional, and neurocognitive outcomes (Q35672786) (← links)
- Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity (Q35685660) (← links)
- A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease (Q35737769) (← links)
- A multicenter feasibility study of chronic graft-versus-host disease according to the National Institute of Health criteria: efforts to establish a Brazil-Seattle consortium as a platform for future collaboration in clinical trials (Q35748144) (← links)
- Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study (Q35794478) (← links)
- Oral disease profiles in chronic graft versus host disease. (Q35796513) (← links)